From the ∗Nuclear Medicine Department, Ente Ospedaliero “Ospedali Galliera,” Genoa
†Clinical and epidemiological research unit, University Hospital of Parma, Parma
‡General Surgery Department
§Internal Medicine Department, Ente Ospedaliero “Ospedali Galliera,” Genoa
∥Nuclear Medicine Department, University of Brescia and ASST Spedali Civili Di Brescia, P.le Spedali Civili, Brescia, Italy
¶Faculty of Biomedical Sciences, Università della Svizzera Italiana (USI), Lugano
∗∗Clinic of Endocrinology and Diabetology, Lugano and Mendrisio Regional Hospital, Ente Ospedaliero Cantonale, Bellinzona, Switzerland.
Received for publication July 1, 2022; revision accepted August 9, 2022.
A.P. and F.F. share coauthorship.
Conflicts of interest and sources of funding: none declared.
The data set used to generate the results presented in the present study is available from the corresponding author on a reasonable request.
Supplemental digital content is available for this article. Direct URL citation appears in the printed text and is provided in the HTML and PDF versions of this article on the journal’s Web site (www.nuclearmed.com).
Correspondence to: Arnoldo Piccardo, MD, Department of Nuclear Medicine, E.O. Ospedali Galliera, Mura delle Cappuccine 14, 16128 Genoa, Italy. E-mail: [email protected].
